BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19
Vaccines (Basel)
; 9(4):01, 2021.
Article
in English
| MEDLINE | ID: covidwho-1208547
ABSTRACT
BNT162b2 is a highly efficacious mRNA vaccine approved to prevent COVID-19. This brief report describes the immunogenicity and anti-viral protective effect of BNT162b2 in hACE2 transgenic mice. Prime-boost immunization with BNT162b2 elicited high titers in neutralizing antibodies against SARS-CoV-2, which correlated with viral clearance and alleviated lung lesions in these mice after viral challenge.
Full text:
Available
Collection:
Databases of international organizations
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
Vaccines (Basel)
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS